RT Journal Article
SR Electronic
T1 Pharmacological Characterization of Histamine Receptors Mediating the Stimulation of Cyclic AMP Accumulation in Slices from Guinea-Pig Hippocampus
JF Molecular Pharmacology
JO Mol Pharmacol
FD American Society for Pharmacology and Experimental Therapeutics
SP 971
OP 982
VO 14
IS 6
A1 J. M. PALACIOS
A1 M. GARBARG
A1 G. BARBIN
A1 J. C. SCHWARTZ
YR 1978
UL http://molpharm.aspetjournals.org/content/14/6/971.abstract
AB A histamine-sensitive adenylate cyclase presenting characteristics very similar to typical H2-receptors has recently been demonstrated in cell-free brain preparations, whereas the stimulation of cyclic AMP accumulation elicited by histamine in cerebral slices has been postulated to involve both H1- and H2-receptors. We have reinvestigated the pharmacological properties of histamine receptors mediating the stimulation of cyclic AMP in guinea-pig hippocampal slices by determining the relative potencies of several agonists and the apparent affinities of antagonists. Metiamide, a H2-blocker, antagonizes in a competitive manner the stimulation elicited by histamine (or 2-thiazolylethylamine, a predominantly H1-agonist) with a pA2 value of 6, corresponding to an interaction with a single population of typical H2-receptors. The relative potencies of two H2-agonists (dimaprit and 4-methylhistamine) are consistent with this view. However other data suggest the involvement of an heterogeneous population of histamine receptors. First, the relative potencies of two H1-agonists (2-thiazolylethylamine and 2-methylhistamine) in hippocampal slices are intermediate between corresponding values on homogeneous populations of H1- and H2-receptors, respectively. Furthermore in the presence of moderate concentrations (5 nM to 0.1 µM) of mepyramine, an H1-antagonist, the response to histamine is modified in a complex fashion: the responses to histamine in low concentrations remain unaltered whereas those to the amine in concentrations above 10 µM are competitively antagonized. Analysis of these data by Schild plot or by a computer program reveals two components in the response to histamine: a first one (insensitive to mepyramine) with an EC50 of 6µM and a second one with an EC50 of 14 µM for the amine (antagonized by mepyramine with a pA2 of 8.2). The participation of each component to the maximal response is approximately 50%. In addition, a series of H1-antagonists inhibit the response to 100 µM histamine with apparent KB 5 toward the second component which appear to be in the same range as those toward typical H1-receptors. Furthermore the supramaximal response to dimaprit, a pure H2-agonist, is progressively elevated in the presence of 2-thiazolylethylamine, a predominantly H1-agonist, in increasing concentrations. In these conditions the relative potency of 2-thiazolylethylamine becomes comparable with the value for typical H1-receptors. This additive response is blocked by 0.1 µM mepyramine while the response to dimaprit alone is not affected. It is concluded that the response to histamine in brain slices involves the stimulation of both typical H2-receptors and receptors closely similar to (or identical with) H1-receptors, which appear to be activated in a sequential manner.